Nick R Lemoine

5PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersAerodynamics (excl. hypersonic aerodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 28, 2025
Correction: Yan et al. Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. <i>Biomedicines</i> 2025, <i>13</i>, 882.

Wenyi Yan, Yujing Xuan, Ruimin Wang

|Jun 03, 2022
MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy.

Renato B Baleeiro, Christian J Bouwens, Peng Liu

|Jan 22, 2021
CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma.

Deepak Raj, Maria Nikolaidi, Irene Garces

|Nov 27, 2019
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer.

Shuangshuang Lu, Zhe Zhang, Pan Du

|Jun 23, 2018
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.

Daniel E Foxler, Katherine S Bridge, John G Foster

Pageof 1

Frequent Collaborators

2 joint publications

Yunshu Dong

1 joint publications

Daniel E Foxler

1 joint publications

Katherine S Bridge

1 joint publications

John G Foster